About
Polaris Genomics develops AI-powered genomic platforms to identify neuropsychiatric biomarkers, aiming to improve diagnosis, treatment, and drug development for mental health and neuropsychiatric disorders.
Explore Polaris Genomics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.